Authors: 
S.L. Minger
Category: 
Invited
Conference: 
Abstract: 

Stem cells offer great therapeutic potential for human disease conditions where the loss of specific cell types is the major pathophysiological feature of individual disorders. Embryonic stem (ES) cells derived from 6-8 day old human embryos offer the most therapeutic potential as these cells are capable of generating every cell and tissue type in the human body. If we can control the differentiation of ES cells, then cell replacement for profound human disorders such as Parkinson’s disease, insulin-dependent diabetes, heart disease, stroke, multiple sclerosis, rheumatoid arthritis, spinal cord damage, and macular degeneration could become standard new therapies. This presentation will examine the state of the art in the development of stem cell therapies and outline some of the technical and ethical considerations as we progress toward clinical and research application of human ES cells.

Keywords (Optional): 
stem cells
regenerative medicine
CNS disorders
diabetes
SENS Research Themes: 
Ending Aging: